Detalhe da pesquisa
1.
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis.
Gastroenterology
; 157(1): 227-241.e7, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30930022
2.
Genome-wide Association Study Identifies Genetic Variants Associated With Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The GIANT-B Study.
Clin Infect Dis
; 69(11): 1969-1979, 2019 11 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30715261
3.
TLR7 Agonist Increases Responses of Hepatitis B Virus-Specific T Cells and Natural Killer Cells in Patients With Chronic Hepatitis B Treated With Nucleos(T)Ide Analogues.
Gastroenterology
; 154(6): 1764-1777.e7, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29378197
4.
Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience.
J Hepatol
; 66(4): 711-717, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27965158
5.
The combination of daclatasvir and sofosbuvir for curing genotype 2 patients who cannot tolerate ribavirin.
Liver Int
; 36(7): 971-6, 2016 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26786792
6.
Interleukin-28B genetic variants in untreated Italian HCV-infected patients: a multicentre study.
Liver Int
; 35(2): 482-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25039676
7.
Treatment optimization and prediction of HCV clearance in patients with acute HCV infection.
J Hepatol
; 59(2): 221-8, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23587473
8.
Limited use of interleukin 28B in the setting of response-guided treatment with detailed on-treatment virological monitoring.
Hepatology
; 54(3): 772-80, 2011 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-21626525
9.
Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR.
Hepatology
; 53(2): 389-95, 2011 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-21274861
10.
An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic response.
Gastroenterology
; 139(3): 821-7, 827.e1, 2010 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-20621700
11.
Progress in promising anti-fibrotic therapies.
Expert Rev Gastroenterol Hepatol
; 13(12): 1145-1152, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31692390
12.
SVR12 Higher than 97% in GT3 Cirrhotic Patients with Evidence of Portal Hypertension Treated with SOF/VEL without Ribavirin: A Nation-Wide Cohort Study.
Cells
; 8(4)2019 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30987413
13.
Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience.
PLoS One
; 14(9): e0223287, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31553772
14.
SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience.
PLoS One
; 14(5): e0215783, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31091254
15.
A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-ß1 dependent mechanisms.
Sci Rep
; 9(1): 1439, 2019 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30723271
16.
Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3.
N Engl J Med
; 352(25): 2609-17, 2005 Jun 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-15972867
17.
Real life rates of sustained virological response (SVR) and predictors of relapse following DAA treatment in genotype 3 (GT3) patients with advanced fibrosis/cirrhosis.
PLoS One
; 13(7): e0200568, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30063745
18.
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes.
Nat Commun
; 5: 5699, 2014 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-25534433
19.
Interleukin 28B polymorphisms as predictor of response in hepatitis C virus genotype 2 and 3 infected patients.
World J Gastroenterol
; 19(47): 8924-8, 2013 Dec 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-24379617
20.
IL28B CC-genotype association with HLA-DQB1*0301 allele increases the prediction of spontaneous HCV RNA clearance in thalassaemic HCV-infected patients.
Antivir Ther
; 16(8): 1309-16, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22155912